News Search Results
Mar 26, 2026, 08:00 ET Averna Therapeutics Announces Strategic Leadership Expansion
growthBOSTON, March 26, 2026 /PRNewswire/ -- Averna Therapeutics, Inc., a biotechnology company developing novel genomic medicines based on gene insertion technology, today announced the appointments of Robert Mabry, Ph.D., as Chief
More news about: Averna Therapeutics
Mar 26, 2026, 08:00 ET Braveheart Bio Appoints Emil deGoma, M.D., as Chief Medical Officer
SAN FRANCISCO, March 26, 2026 /PRNewswire/ -- Braveheart Bio, a clinical-stage biotechnology company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiovascular conditions, today announced the
More news about: Braveheart Bio
Mar 26, 2026, 08:00 ET Pulmatrix and Eos SENOLYTIX Announce Merger Agreement to Advance Novel Mitochondrial Therapies to Improve Healthspan
mitochondrial therapeutics. He is supported by a team of experienced biotechnology executives, scientists and advisors with prior leadership roles at major pharmaceutical companies, academic medical centers and emerging biotechnology firms."We believe the focus in obesity will shift from
More news about: Pulmatrix Inc.
Mar 26, 2026, 07:30 ET Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Pinnacle Medicines ("Pinnacle" or "the Company"), a biotechnology company pioneering the development of oral peptide therapeutics using proprietary AI and physics-based platforms, today announced the closing of
More news about: Pinnacle Medicines
Mar 26, 2026, 07:30 ET Soligenix Receives Orphan Drug Designation from the European Commission for SGX945 for the Treatment of Behçet's Disease
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Mar 26, 2026, 06:00 ET Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda™ (tarcocimab tedromer) Over Sham
Calif., March 26, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina-focused biotechnology company committed to researching, developing and commercializing transformative therapeutics, today announced positive topline results in the GLOW2
More news about: Kodiak Sciences Inc.
Mar 25, 2026, 20:50 ET Human Longevity, Inc. and LEV Foundation Announce Strategic Collaboration to Decode Biological Drivers of Exceptional Longevity
extending healthspan across the global population.About Human Longevity, Inc.Founded in 2013, Human Longevity, Inc. is a biotechnology company at the forefront of integrating genomics, artificial intelligence, and multimodal diagnostics to extend human healthspan. Through its flagship
More news about: Human Longevity, Inc.
Mar 25, 2026, 19:01 ET WesternU College of Podiatric Medicine achieves 100% residency placement for 13 consecutive years
www.westernu.edu), located in Pomona, Calif. and Lebanon, Ore., is an independent nonprofit health professions university, conferring degrees in biotechnology and pharmaceutical sciences, dental medicine, medical sciences, nursing, optometry, osteopathic medicine, pharmacy, physical therapy, physician
More news about: Western University of Health Sciences
Mar 25, 2026, 16:05 ET Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2025 Financial Results
March 25, 2026 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat
More news about: Armata Pharmaceuticals, Inc.
Mar 25, 2026, 12:00 ET The Mark Foundation for Cancer Research Announces Global Expansion and $1M Funding Boost for Flagship Emerging Leader Award
tumors. In the eight years since the program was launched, recipients' work has already led to high-impact papers, clinical trials, and innovative biotechnology companies.For more information about the program, eligibility requirements, and application instructions, visit
More news about: The Mark Foundation for Cancer Research
Mar 25, 2026, 11:29 ET Rubin Rudman Adds Meredith Havard to Trusts & Estates and Fiduciary Litigation Groups
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; hospitality companies; regulated industries, public entities and municipalities; insurance companies
More news about: Rubin Rudman
Mar 25, 2026, 10:45 ET Veterinary Diagnostics Market Size Worth USD 19.63 Billion by 2032, Exclusive Report by Maximize Market Research
Agrolabo S.p.A. (Italy)Asia-Pacific17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)18. Shenzhen Bioeasy Biotechnology Co. Ltd. (China)19. BioNote Inc. (South Korea)20. FUJIFILM Holdings Corporation (Japan)21. IM3Vet Pty Ltd. (Australia)Get
More news about: Maximize Market Research Pvt. Ltd.
Mar 25, 2026, 09:14 ET SOCMA Sees Strong Membership Growth with 13 New Members in Q1 2026
Contract Research, Development, and Manufacturing Organization committed to delivering innovative solutions for clients in the pharmaceutical, biotechnology, and other industries. Laxai "saw value in SOCMA as the premier organization in North America providing technical, operational, regulatory and commercial
More news about: Society of Chemical Manufacturers & Affiliates
Mar 25, 2026, 09:00 ET Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation
remains central to Locus FS's approach. Through precision microbial design and high-performing glycolipid biosurfactants, the company leverages biotechnology to develop biological alternatives that address complex operational, agronomic, and formulation challenges. Its unified, platform-driven process
More news about: Frost & Sullivan
Mar 25, 2026, 09:00 ET Frost & Sullivan: Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition for Excellence in Platform-Driven Biological Innovation
remains central to Locus FS's approach. Through precision microbial design and high-performing glycolipid biosurfactants, the company leverages biotechnology to develop biological alternatives that address complex operational, agronomic, and formulation challenges. Its unified, platform-driven process
More news about: Frost & Sullivan
Mar 25, 2026, 09:00 ET Merlin CP-GEP™ Demonstrates Superior Predictive Accuracy for Sentinel Lymph Node Metastasis in Early-Stage Melanoma
www.merlinmelanomatest.com.About SkylineDxSkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, and inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Mar 25, 2026, 08:30 ET PTC Therapeutics Appoints Biotech Banking Pioneer Jessica Chutter to Board of Directors
Managing Director and Chair of Biotechnology Investment Banking of Morgan Stanley after a distinguished career spanning over 40 years. She helped build the biotechnology banking practice at Morgan Stanley and is widely considered a pioneer in establishing the field of biotechnology investment banking. During
More news about: PTC Therapeutics, Inc.
Mar 25, 2026, 08:29 ET Lupin Receives Tentative Approval from U.S. FDA for Pitolisant Tablets
products distributed in over 100 markets. Lupin specializes in pharmaceutical products, including branded and generic formulations, complex generics, biotechnology products, and active pharmaceutical ingredients. Trusted by healthcare professionals and consumers globally, the company enjoys a strong position
More news about: Lupin Pharmaceuticals, Inc.
Mar 25, 2026, 08:20 ET Cresilon Named One of the World's 50 Most Innovative Companies by Fast Company
fastcompany.com. It will also appear on newsstands beginning March 31, 2026.About CresilonCresilon® is a Brooklyn-based biotechnology company that develops, manufactures, and markets hemostatic medical devices using its proprietary hydrogel technology. The company's plant-based
More news about: Cresilon
Mar 25, 2026, 08:00 ET Kalohexis Announces Publication in Frontiers in Endocrinology Defining Design Criteria for Next-Generation Melanocortin Drugs for General Obesity
NORTHBROOK, Ill., March 25, 2026 /PRNewswire/ -- Kalohexis, a clinical-stage biotechnology company harnessing the melanocortin system to shape the next era of metabolic disease care starting with obesity and cancer cachexia, today announced
More news about: Kalohexis
Mar 25, 2026, 08:00 ET Alteogen Enters into a License Agreement with Biogen for Development and Commercialization of Hybrozyme™-Based Subcutaneous Biologics
receive royalties based on net sales.Under the agreement, Biogen also holds an option to develop a third product."Biogen is a global biotechnology company leading innovation with strong research and development capabilities. We are very pleased to enter into this partnership and look forward
More news about: Alteogen Inc.
Mar 25, 2026, 08:00 ET VERIGRAFT Advances First Potential Curative Treatment for CVI into Pivotal Phase II/III Trial
GOTHENBURG, Sweden, March 25, 2026 /PRNewswire/ -- VERIGRAFT, a Swedish clinical-stage biotechnology company pioneering personalized, fully biological therapies, today announced the initiation of a pivotal Phase II/III trial of its P-TEV (personalized
More news about: VERIGRAFT
Mar 25, 2026, 06:05 ET MGI Tech Brings High-Throughput T7+ Sequencer to European Market at Analytica 2026 Debut
focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. We provide real-time, multi-omics, and a full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare, and various
More news about: MGI Tech Co., Ltd.
Mar 25, 2026, 06:00 ET HanchorBio Advances Toward TWSE Innovation Board Listing to Accelerate Global Clinical Development, Platform Expansion, and International Partnering
SAN FRANCISCO, March 25, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation multifunctional biologics across oncology and immune-related diseases, today announced that it has received approval
More news about: HanchorBio Inc.
Mar 25, 2026, 06:00 ET Waterdrop Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results and Declares a Cash Dividend
clinical trial solution income represents the service income earned from our customers mainly including biopharmaceutical companies and leading biotechnology companies. We match qualified and suitable patients for enrollment in clinical trials for our customers and generate digital clinical trial solution
More news about: Waterdrop Inc.